2.01
price down icon9.05%   -0.20
 
loading
전일 마감가:
$2.21
열려 있는:
$2.275
하루 거래량:
5.33M
Relative Volume:
0.33
시가총액:
$251.79M
수익:
-
순이익/손실:
$-112.46M
주가수익비율:
-1.2256
EPS:
-1.64
순현금흐름:
$-99.89M
1주 성능:
-15.90%
1개월 성능:
+736.50%
6개월 성능:
+47.80%
1년 성능:
+117.71%
1일 변동 폭
Value
$1.98
$2.31
1주일 범위
Value
$1.92
$2.65
52주 변동 폭
Value
$0.1311
$3.29

보 바이오파마 Stock (VOR) Company Profile

Name
명칭
Vor Biopharma Inc
Name
전화
617-655-6580
Name
주소
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Name
직원
168
Name
트위터
Name
다음 수익 날짜
2024-11-05
Name
최신 SEC 제출 서류
Name
VOR's Discussions on Twitter

VOR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
VOR
Vor Biopharma Inc
2.015 298.65M 0 -112.46M -99.89M -1.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.70 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.76 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.81 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
565.44 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
290.80 27.29B 3.81B -644.79M -669.77M -6.24

보 바이오파마 Stock (VOR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-30 업그레이드 H.C. Wainwright Neutral → Buy
2022-07-26 개시 Wedbush Outperform
2022-04-27 개시 Goldman Neutral
2021-12-17 개시 H.C. Wainwright Buy
2021-12-03 개시 Robert W. Baird Outperform
2021-12-02 개시 Oppenheimer Outperform
2021-10-19 개시 JMP Securities Mkt Outperform
2021-03-25 개시 B. Riley Securities Buy
2021-03-03 개시 Barclays Overweight
2021-03-03 개시 Evercore ISI Outperform
2021-03-02 개시 Goldman Sell
2021-03-02 개시 Stifel Buy
모두보기

보 바이오파마 주식(VOR)의 최신 뉴스

pulisher
01:45 AM

Vor Biopharma Inc. Stock Analysis and ForecastSuperior stock growth - Autocar Professional

01:45 AM
pulisher
08:30 AM

Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors - Stock Titan

08:30 AM
pulisher
Jul 20, 2025

Is Vor Biopharma Inc. a good long term investmentExplosive portfolio gains - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

H.C. Wainwright Upgrades Vor Biopharma (VOR) to a Buy, Sets a $3 Price Target - MSN

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about Vor Biopharma Inc. stockRapid return acceleration - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Vor Biopharma Inc. stock priceExceptional trading performance - Jammu Links News

Jul 20, 2025
pulisher
Jul 20, 2025

Vor Biopharma's Strategic Turnaround and the Case for Immediate Investment - AInvest

Jul 20, 2025
pulisher
Jul 19, 2025

Vor Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - AInvest

Jul 19, 2025
pulisher
Jul 18, 2025

10 Hot Penny Stocks to Invest in Now - Insider Monkey

Jul 18, 2025
pulisher
Jul 18, 2025

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jul 18, 2025
pulisher
Jul 18, 2025

Vor Bio Awards Massive 5.3M Share Package to New Development Chief: Full Grant Details Revealed - Stock Titan

Jul 18, 2025
pulisher
Jul 18, 2025

Vor Biopharma shares rise 2.52% premarket after appointing Qing Zuraw as Chief Development Officer. - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Why Vor Biopharma Inc. stock is on top investor watchlistsFree Real-Time Market Predictions - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Vor Bio Appoints Qing Zuraw, M.D. as Chief Development Officer - Yahoo Finance

Jul 17, 2025
pulisher
Jul 16, 2025

Vor Biopharma Faces Crucial Market Shifts Amid Latest Developments - StocksToTrade

Jul 16, 2025
pulisher
Jul 16, 2025

Vor Biopharma Stock Faces Volatile Week Amid Mixed Financial Reports - timothysykes.com

Jul 16, 2025
pulisher
Jul 16, 2025

Vor Biopharma Inc. shares rise 2.00% premarket after Bonesupport CEO predicts strong growth. - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

How Vor Biopharma Inc. stock performs during market volatilitySafe Entry High Exit Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Vor Biopharma Inc. stock price move sharplySteady Profit Stock Forecasts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Vor Biopharma Inc. stock attracts strong analyst attentionBreakout Confirmation Tool - newser.com

Jul 15, 2025
pulisher
Jul 14, 2025

Vor Biopharma Stock’s Rollercoaster: Time to Buy?​ - StocksToTrade

Jul 14, 2025
pulisher
Jul 14, 2025

VOR’s 2025 Market Dance: Up 174.66% – Time to Invest? - investchronicle.com

Jul 14, 2025
pulisher
Jul 11, 2025

Vor Biopharma Explodes 22% – What’s Fueling the Surge? - AInvest

Jul 11, 2025
pulisher
Jul 10, 2025

Vor Biopharma Names Sandy Mahatme as CFO, Chief Business Officer - MarketScreener

Jul 10, 2025
pulisher
Jul 10, 2025

Vor Bio Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer - The Manila Times

Jul 10, 2025
pulisher
Jul 10, 2025

Vor Bio Strengthens Leadership: Top Biotech Executive Who Raised $6B Joins as New CFO/CBO - Stock Titan

Jul 10, 2025
pulisher
Jul 09, 2025

Vor Biopharma shares rise 5.83% intraday after $41B telitacicept licensing deal and HC Wainwright upgrade. - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Vor Biopharma Sees Unusually High Options Volume (NYSE:VOR) - Defense World

Jul 09, 2025
pulisher
Jul 08, 2025

Vor Biopharma Shares Soar 23.22% on Analyst Upgrades - AInvest

Jul 08, 2025
pulisher
Jul 08, 2025

Vor Biopharma: Not So Sure About This Surge, And Do Mind The Warrants - Seeking Alpha

Jul 08, 2025
pulisher
Jul 08, 2025

VOR’s Unexpected Surge: What’s Driving the Spike? - timothysykes.com

Jul 08, 2025
pulisher
Jul 08, 2025

VOR Biopharma Inc. Faces Uncertain Future Amid Recent Developments - StocksToTrade

Jul 08, 2025
pulisher
Jul 08, 2025

Vor Biopharma Soars 19.1% on Analyst Upgrade - AInvest

Jul 08, 2025
pulisher
Jul 07, 2025

Vor Biopharma Stock Skyrockets: What’s Next? - StocksToTrade

Jul 07, 2025
pulisher
Jul 07, 2025

Vor Biopharma shares surge 28.01% intraday after licensing telitacicept for autoimmune diseases and raising $1.75B in private funding. - AInvest

Jul 07, 2025
pulisher
Jul 05, 2025

Vor Biopharma Inc. (NYSE:VOR) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jul 05, 2025
pulisher
Jul 02, 2025

Vor Biopharma (NASDAQ:VOR) Stock Rating Upgraded by HC Wainwright - Defense World

Jul 02, 2025
pulisher
Jul 01, 2025

Vor Bio Report Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jul 01, 2025
pulisher
Jul 01, 2025

Massive CEO Stock Grant: Vor Bio Awards 83M Shares to New Chief Executive at $0.89 - Stock Titan

Jul 01, 2025
pulisher
Jun 30, 2025

Vor Biopharma's RemeGen Deal Paves Way For Multi-Billion Dollar Autoimmune Market - Benzinga

Jun 30, 2025

보 바이오파마 (VOR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.67
price down icon 1.03%
$35.60
price up icon 0.17%
$102.58
price down icon 0.03%
$26.88
price up icon 1.05%
$110.44
price down icon 0.20%
biotechnology ONC
$290.46
price down icon 1.81%
자본화:     |  볼륨(24시간):